Prevention of bleeding and edema in bi-maxillary orthognathic surgery; the effectiveness of tranexamic acid on intraoperative bleeding in orthognathic surgery - Prevention of bleeding in bi-maxillary orthognathic surgery; the effectiveness of tranexamic acid on

Hospital of South West Jutland0 个研究点开始时间: 2014年3月6日最近更新: 2017年1月9日

适应症

试验速览

暂无简介。

•Patients must be healthy, 18 years or older, and present with no known medical conditions incl. significantly reduced renal function. All patients must be sceduled for routine orthognathic surgery at the department of maxillofacial surgery at the hospital of South West Jutland.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 80
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Patients must not present with sensitivity to tranexamic acid, acute venous/arterial thrombosis, fibrinolytic conditions due to disseminated intravascular coagulation, except for instances of predominant activation of the fibrinolytic system in regards to acute severe bleeding. Severe reduced renal function, medical history reporting cramps. Intake of Omega 3 fatty acids, Gingko Biloba, ginger and garlic dietary supplements <10 days prior to surgery. Pregnancy (will be tested for on the day of surgery via urine test).

发起方

Hospital of South West Jutland